Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2013-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2013-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Recursion Pharmaceuticals, Inc. (RXRX) | former Chief Executive Officer and President and current Chair of the Board | $680,000 | $9,607,508 |
| 2024 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $600,000 | $8,499,587 |
| 2023 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $560,833 | $8,613,209 |
| 2022 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $497,500 | $6,315,903 |
| 2021 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $485,417 | $673,591 |
| 2020 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $269,643 | $2,584,448 |
Earnings-call appearances and filed executive appointments or departures, newest first.
